Paul Conyngham, an Australian technology enthusiast, developed a custom mRNA vaccine for his cancer-stricken dog, Rosie.
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
So he turned to AI and eventually developed a custom a mRNA cancer vaccine with the help of Australian scientists. Most of Rosie’s tumors have shrunk, and the dog is back chasing rabbits.
A Sydney data engineer has developed the world's first personalised mRNA cancer vaccine for a dog using AI tools like ChatGPT ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are spending billions to bring the same technology to human patients.
Riddled with cancer, Rosie the rescue dog had only months to live, until her dogged owner collared a chatbot to collaborate with elite medical scientists in the quest for a cure.
Paul Conyngham claims he used AI tools like ChatGPT and AlphaFold to create custom mRNA vaccines that helped cure his dog’s cancer after traditional treatments failed to stop the tumour.
6hon MSN
Techie shrinks dog's tumor by half after using ChatGPT to design ‘first personalized cancer vaccine’
Techie Paul Conyngham developed a custom mRNA vaccine for his dog, Rose, using ChatGPT and AlphaFold. The AI-assisted process ...
An AI-designed mRNA vaccine has successfully treated a Sydney dog with cancer, shrinking her tumor by half and offering hope ...
10hon MSN
AI’s finest hour: Tech executive uses ChatGPT to create cancer vaccine that saved his dog’s life
A tech executive utilized artificial intelligence and genomic analysis to develop a personalized experimental cancer vaccine for his dog, Rosie. This innovative approach, combining AI, genomics, and ...
Interesting Engineering on MSN
ChatGPT helps create groundbreaking cancer treatment after dog’s diagnosis
Eight-year-old dog Rosie, once abandoned in bushland, found a new lease on life when ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results